ISSN 1662-4009 (online)

ey0017.1-10 | Clinical Highlights | ESPEYB17

1.10. Significant benefits of AIP testing and clinical screening in familial isolated and young-onset pituitary tumors

Marques Pedro , Caimari Francisca , Hernandez-Ramirez Laura C. , Collier David , Iacovazzo Donato , Ronaldson Amy , Magid Kesson , Lim Chung Thong , Stals Karen , Ellard Sian , Grossman Ashley B. ,

To read the full abstract: J Clin Endocrinol Metab. 2020 Jan 30. pii: dgaa040. doi: 10.1210/clinem/dgaa040. PMID: 31996917.The International FIPA Consortium recommend that aryl hydrocarbon receptor-interacting protein (AIP ) gene mutations are worth screening for prospectively in family members of AIPmut patients, and the detected carriers should be clinically followed. AI...